Takashi Sugane
Head, Candidate Delivery, Engineered Small Molecules Astellas Pharma
Seminars
Wednesday 28th October 2026
Optimizing Novel Heterobifunctional Degraders – An Update
2:45 pm
- Overview of Astellas’ TPD approach to overcome undruggable targets
- Updating next-generation degrader candidates
- Emerging DAC approaches to deliver TPD molecules to tumor tissues
